{"id":141258,"title":"Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T22:23:31.460000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/considerations-inclusion-women-clinical-trials.html?wbdisable=false","snippet":"Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu…","rawSnapshotUrl":"/api/snapshots/raw/141258","browseUrl":"https://replay.healtharchive.ca/job-1/20250418222331/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/considerations-inclusion-women-clinical-trials.html?wbdisable=false#ha_snapshot=141258","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}